| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/01/2005 | US6849749 Method for the preparation of citalopram |
| 02/01/2005 | US6849742 Binaphthol derivative and process for producing the same |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849574 Silver- and vanadium-containing multimetal oxide and its use |
| 02/01/2005 | US6849097 I.e., N-(thiophen-2 or-3-ylmethyl)-, N-(furan-3-ylmethyl)-, N-(1H-imidazol-2-ylmethyl)- and N-(pyrrol-2-ylmethyl)-p-phenylenediamines; developers for hair dyes |
| 02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same |
| 02/01/2005 | CA2133324C Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007625A2 Heterocyclic amides with anti-tuberculosis activity |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007103A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | WO2004108673A3 Inhibitors of papilloma virus |
| 01/27/2005 | WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020673 reduction; cyclization catalytic hydrogenation |
| 01/27/2005 | US20050020670 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020635 C7 carbamoyloxy substituted taxane compositions |
| 01/27/2005 | US20050020609 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 01/27/2005 | US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood |
| 01/27/2005 | US20050020588 Cysteine protease inhibitors |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/27/2005 | US20050015898 Hair dyes for keratin fibers |
| 01/27/2005 | CA2532229A1 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
| 01/26/2005 | EP1500656A1 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 01/26/2005 | EP1499604A1 Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentaidenoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 01/26/2005 | EP1499603A1 Antiviral lactone-ureas |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | EP1499573A1 Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1185524B1 3-heteroarylalkyl substituted gaba analogs |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571780A Synthetic method of 2-(2-nitroethylenyl)-furan and its purpose as anti-coccidium agent |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1569849A Rosa banksiae general lactone extract and its preparing process and application |
| 01/26/2005 | CN1569848A Ligustilide for treating ischemic heart disease and its preparing method |
| 01/26/2005 | CN1569847A Process for preparing ranitidine bismuth citrate or ranitidine bismuth trtrate compositions |
| 01/26/2005 | CN1186334C Pharmaceutical application of benzofuranone derivatives |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846936 Intermediate for 2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-nitrobenzofur an, used in preparation of dronedarone |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/25/2005 | US6846389 Multistage process; separation by boiling points |
| 01/25/2005 | CA2290127C Method for the preparation of citalopram |
| 01/20/2005 | WO2005005956A2 Fluorophore compounds and their use in biological systems |
| 01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2004103941A3 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 01/20/2005 | WO2004099145A3 Phenyl substituted cyclic derivatives |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 01/20/2005 | US20050014820 formed via acid-catalyzed cyclization, with production of methamine end-products; for treatment of central nervous system disorders |
| 01/20/2005 | US20050014791 Inhibitors of papilloma virus |
| 01/20/2005 | US20050014765 Aryl-heteroaromatic products, compositions comprising them and use |
| 01/20/2005 | US20050014751 Modulate immunology response; prevent lymphocyte proliferation; immunosuppressants; autoimmune disease |
| 01/20/2005 | US20050014750 Isochroman compounds for treatment of cns disorders |
| 01/20/2005 | US20050014651 Abscisic acid biosynthesis inhibitor |
| 01/20/2005 | US20050014092 Novel compound, polymer, resist composition, and patterning process |
| 01/20/2005 | US20050013859 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1498109A1 Furan derivatives and dyeing composition comprising a furan derivative as coupler |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497257A1 2,5-bis-diamine-[1,4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 01/19/2005 | EP1497245A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 01/19/2005 | EP1497028A2 Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst |
| 01/19/2005 | EP1406887B1 Method for the selective production of tetrahydrofuran by hydrogenating maleic acid anhydride |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1568319A Systems and methods for generation of ascorbic acid with reduced color |
| 01/19/2005 | CN1568303A Oligofluorenylene compounds |
| 01/19/2005 | CN1568299A Method for the isolation of salts of organic acids from a fermentation broth and for releasing the organic acid |
| 01/19/2005 | CN1568228A Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1568183A Citalopram for the treatment of elevated blood pressure |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566054A Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1185244C Rebescensine A derivatives and preparing process thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/18/2005 | US6844452 Multistage hydrogenation; byproduct inhibition |
| 01/18/2005 | US6844451 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of Ginkgo biloba |
| 01/18/2005 | US6844358 Protein tyrosine phosphatase inhibitors; benzofuran-3-yl- or benzothiophen-3-yl derivatives; containing pyridinyl, imid-azoyl, oxazoyl or thiazoyl functionality |
| 01/18/2005 | US6844309 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 01/13/2005 | WO2005003110A1 6-trifluoromethyl-2-vinyloxy-4-oxatricyclo[4. 2. 1. 03, 7]noname-5-one, and polymer compound |
| 01/13/2005 | WO2005002582A2 Trp-p8 active compounds and therapeutic treatment methods |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050009930 Carotenoid analogs or derivatives for controlling connexin 43 expression |
| 01/13/2005 | US20050009920 Taxol enhancer compounds |
| 01/13/2005 | US20050009907 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |